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Abstract
How stage-specific enhancer dynamics modulate gene expression patterns essential for organ 
development, homesostasis, and disease is not well understood. Here, we addressed this question 
by mapping chromatin occupancy of GATA4—a master cardiac transcription factor—in heart 
development and disease. We find that GATA4 binds and participaes in establishing active 
chromatin regions by stimulating H3K27ac deposition, which facilitates GATA4-driven gene 
expression. GATA4 chromatin occupancy changes markedly between fetal and adult heart, with a 
limitted binding sites overlap. Cardiac stress restored GATA4 occupancy to a subset of fetal sites, 
but many stress-associated GATA4 binding sites localized to loci not occupied by GATA4 during 
normal heart development. Collectively, our data show that dynamic, context-specific 
transcription factors occupancy underlies stage-specific events in development, homeostasis, and 
disease.
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Introduction
Transcription factors (TFs) drive spatiotemporal patterns of gene expression that control the 
development of organs and their responses to disease. How TFs are redeployed to regulate 
distinct stage-specific gene expression programs is not well understood. A fundamental step 
towards answering this question is to delineate dynamic changes in TF occupancy and 
chromatin context in development and disease.
Development of the heart is orchestrated by a set of cardiac TFs. In adult heart disease, 
many of the same TFs regulate the heart's stress responses1. Indeed, many fetally expressed 
genes are re-expressed in adult heart disease, and this has been interpreted as disease-
induced reactivation of a fetal transcriptional program. To gain insights into how cardiac TF 
activity is regulated to drive stage-specific transcriptional program, we studied the master 
cardiac TF GATA4, which is required in the heart from cardiomyocyte specification through 
adulthood2–7.
Using a knock-in allele of GATA4 that is biotinylated in vivo to permit high affinity 
GATA4 pulldown8, we mapped the changes in GATA4 chromatin occupancy that occur 
between fetal versus adult heart. GATA4 bound to loci with active chromatin signatures, and 
indeed GATA4 contributed to establishing this active chromatin signature by stimulating 
H3K27ac deposition, which facilitated GATA4-driven gene activation. Furthermore, our 
data revealed that some GATA4 binding sites are maintained between fetal and adult heart, 
but that most change dynamically between developmental stages. GATA4 occupancy 
studies of control versus pressure overloaded adult heart similarly showed that some fetal 
GATA4 bound regions were restored in cardiac hypertrophy, but most hypertrophy-induced 
GATA4 regions were newly established elements of an adult hypertrophic transcriptional 
program.
RESULTS
Identification of GATA4 regulated enhancers in fetal heart
We previously reported an allele of GATA4 in which the endogenous gene has been 
modified to incorporate FLAG and bio (flbio) epitope tags8,9, where bio is a 23 amino acid 
sequence specifically biotinylated by the enzyme BirA10. In GATA4flbio/flbio::Rosa26BirA/+ 
mice, GATA4flbio is pulled down with high affinity onto immobilized streptavidin. The 
GATA4flbio allele retains full or nearly full activity11. Using this high affinity system, we 
identified GATA4 peaks in E12.5 heart ventricles by bioChIP-seq. In each of two biological 
duplicate samples, we identified over 50,000 GATA4-bound regions (hereafter referred to as 
GATA4 regions), with 43,800 (85.0%) shared between the duplicates (Fig. 1a; 
Supplementary Data 1). 50.8% of these regions overlapped with GATA4flbio binding sites in 
HL1 cardiomyocyte-like cells.8 We also performed GATA4 antibody-based ChIP-seq and 
found that it was less sensitive, identifying 11,915 (72.7%) regions that were shared between 
biological duplicates (Fig. 1a). 11,561 of these regions (97%) were also enriched by the 
GATA4 bioChIP-seq. We refer to these peaks shared between all four samples as high 
confidence fetal GATA4 regions.
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GATA4 interacts with the transcriptional co-activator and histone acetyltransferase p30012, 
and GATA4 enhances p300 recruitment to chromatin loci8. Therefore, we asked if heart 
p300 binding sites13 were over-represented near high confidence fetal heart GATA4 peaks 
(Fig. 1b). Indeed, heart p300 ChIP-seq reads were strongly enriched on GATA4 peaks, but 
midbrain p300 ChIP-seq reads were not (Fig. 1b; p=2.0E-10). Because the fetal p300-bound 
regions were predictive of fetal heart enhancer activity13, these data indicate that GATA4 
regions contain functional transcriptional enhancers. These data extend this work to provide 
unbiased, genome-wide support for GATA4 recruitment of p300 to heart enhancers.
Identifying genes directly activated by GATA4
We used RNA-seq on E12.5 cTNT-Cre::Gata4fl/fl (G4CKO) and control heart ventricles to 
identify genes regulated downstream of GATA4. There were 1720 differentially expressed 
genes (log2 fold change >0.5). GATA4 promoted expression of 726 genes (i.e., 
downregulated in loss of GATA4), and 211 of them were associated with one or more 
GATA4 regions (p < 7.99E-04) (Fig. 1c and Supplementary Data 2). These 211 genes are 
likely to be directly activated by GATA4, and their 511 associated GATA4 regions are 
candidate GATA4-dependent enhancers. The 211 genes were over-represented for Gene 
Ontology (GO) terms linked to heart and muscle development (Supplementary Fig. 1a). One 
example is Ednra, encoding an endothelin receptor, which was downregulated 2-fold in 
GATA4 loss of function and was linked to a strong GATA4 region 264 kb upstream of the 
transcriptional start site (TSS; Fig. 1d) as well as two additional intergenic peaks 
downstream of Ednra (not shown). In addition, 422 genes that were bound by GATA4 and 
up-regulated in G4CKO heart ventricles (Supplementary Fig. 1b), suggestive of direct 
GATA4-mediated repression. These 422 genes were over-represented for genes with 
functional annotations related to heart and vasculature development (Supplementary Fig. 
1c).
To evalaute the prediction that GATA4 regions linked to the 211 GATA4-activated genes 
are functional transcriptional enhancers, we tested 12 candidates linked to 4 genes (Ednra, 
Hey2, Kcne1, and Hopx) in transient transgenic enhancer assays. 7 of these 12 enhancers 
(58.3%) were active in the heart (Table 1; Fig. 2a and Supplementary Fig. 2), although the 
activity of one of these, Hey2-8, was confined to non-cardiomyocytes of the outflow tract 
cushion. We previously tested putative enhancers based on multiple transcription factor 
occupancy in cardiomyocyte-like HL1 cells, and one of these tested enhancers met the 
criteria used to select enhancers for this study8. This enhancer also exhibited strong heart 
transcriptional activity. Overall, a GATA4 region linked to gene downregulation in G4CKO 
predicted heart enhancer activity (8/13, 61.5%), comparable to the frequency of p300-bound 
regions with heart enhancer activity (62.3%, ref. 14). The highest frequency of heart 
enhancer activity occurred for regions bound by both GATA4 and p300 (8/9, 88.9%).
We next asked if GATA4 binding is essential for activity of these GATA4-occupied 
enhancers. We mutated the consensus GATA4 motifs found under the high confidence 
GATA4 peaks of 3 enhancers (Ednra-172, Wisp1, and Ssh2) with heart activity (Table 1). 
Mutation of the GATA motifs in the Wisp1 and Ssh2 enhancers ablated cardiac enhancer 
activity (Fig. 2b). However, mutation of the GATA motif in Ednra-172 did not (Fig. 2b), 
He et al. Page 3
Nat Commun. Author manuscript; available in PMC 2015 March 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
although the mutated enhancer tested still contained an additional GATA motif with 
significant GATA4 occupancy by bioChIP-seq. We previously reported on the in vivo 
GATA4-dependence of a fourth region related to Smarcd38, where mutation of both a 
GATA4 and a TBX5 motif blocked enhancer activity. In summary, GATA motifs were 
essential for the heart activity of three of four tested GATA4-bound heart enhancers (Table 
1).
GATA4 promotes deposition of H3K27ac at distal enhancers
Fetal GATA4 predominantly binds to distal transcriptional enhancer sequences that are 
enriched in p300 occupancy. p300 acetylates histone H3 at lysine 27 (H3K27ac), a major 
active transcriptional enhancer15,16 mark. We hypothesized that an important mechanism by 
which GATA4 promotes cardiac gene transcription is through GATA4-dependent H3K27ac 
deposition. To test this hypothesis, we defined the genome-wide chromatin occupancy of 
H3K27ac in E12.5 heart ventricle by ChIP-seq. There was extensive overlap between distal 
H3K27ac and GATA4 chromatin occupancy (Fig. 3a), as well as substantial overlap 
(76.3%) between their associated genes (Fig. 3b). Regions bound by both GATA4 and 
H3K27ac were linked to heart development GO terms (orange bars, Fig. 3c), while those 
bound by each factor alone were not.
We evaluated the relationship of distal GATA4 or H3K27ac occupancy to the expression of 
associated genes. The most highly expressed group of genes was associated with distal 
regions enriched for both GATA4 and H3K27ac (Fig. 3d). Genes with distal regions 
enriched for H3K27ac but not GATA4 were expressed at nearly the same level. In 
comparison, genes with distal regions enriched for GATA4 but not H3K27ac were 
expressed at lower levels, and genes with distal regions lacking either feature were the 
lowest expressed. Increasing expression of GATA4-bound genes correlated with higher 
H3K27ac enrichment but not with the degree of GATA4 binding (Fig. 3e). In fact, fetal 
heart genes directly activated by GATA4 (bound by GATA4 and downregulated in G4CKO) 
had significantly higher H3K27ac enrichment than genes unaffected or repressed by GATA4 
(Fig. 3f). In comparison, GATA4 enrichment was not substantially different between genes 
activated, repressed, or unaffected in G4CKO (Fig. 3f). Together, these data indicate that 
H3K27ac but not GATA4 signal strength associates with higher gene expression.
To test the hypothesis that distal GATA4 occupancy promotes H3K27ac deposition, we 
measured the effect of cardiomyocyte-specific loss of GATA4 on H3K27ac chromatin 
occupancy (Fig. 3g). H3K27ac ChIP-seq on E12.5 G4CKO or control (Gata4fl/fl) heart 
ventricles demonstrated marked reduction of H3K27ac at 73.3% of fetal distal GATA4 
regions, compared to H3K27ac increase at only 5.2% of these regions (Fig. 3g; Fisher exact 
P < 8.95E-321). We confirmed this result by preparing chromatin from independent E12.5 
G4CKO or control heart ventricles and measuring H3K27ac enrichment by ChIP-qPCR. At 9 
of 10 distal fetal GATA4 regions examined, including prospective enhancers of Ppargc1a, 
Prkag2, Ryr2, Tnnt1, Hey2, and Ednra, GATA4 inactivation significantly reduced H3K27ac 
enrichment (Fig. 3h). On the other hand, GATA4 gain-of-function in HL1 cardiomyocyte-
like cells significantly increased H3K27ac enrichment at 8 of these regions (Fig. 3h).
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Together, these data show that GATA4 plays a permissive role in gene regulation, but its 
binding strength as assessed by ChIP-seq does not correlate with the level of gene 
transcription. Rather, GATA4 stimulates deposition of H3K27ac, which then drives cardiac 
gene expression.
Dynamic changes in GATA4 binding during development
To determine changes in GATA4 chromatin occupancy that occur during normal 
development, we performed GATA4 bioChIP-seq on adult heart ventricles. In biological 
duplicate samples, we identified greater than 15,000 binding sites, with 13504 (83.4%) 
overlapping between replicates. Previously reported GATA4 antibody ChIP-seq from whole 
adult heart identified less than one seventh the number of GATA4 regions (1756)17, 
although 69.6% of these overlapped with our bioChIP-seq peaks. By contrast, GATA4 
antibody ChIP-seq identified 4409 GATA4 regions in adult fetal liver,18 and only 22.8% of 
these regions overlapped our heart ventricle bioChIP-seq peaks. These data suggest that 
most GATA4 chromatin occupancy is tissue specific.
We compared the peaks shared by biological duplicate bioChIP-seq samples from fetal heart 
to those from adult (Fig. 4a–b; Supplementary Fig. 3a; Supplementary Data 1). Of the 13504 
adult GATA4 regions, 8716 (66.5%) "Shared" regions were reproducibly also occupied by 
GATA4 in fetal heart. On the other hand, 4339/13504 (33.5%) adult GATA4 regions were 
not bound by GATA4 in fetal heart ("Adult-Specific"), and 35084/43800 (80.1%) fetal 
GATA4 regions were not bound by GATA4 in adult heart ("Fetal-Specific"). While reduced 
GATA4 expression in the adult heart (Supplementary Fig. 3b) may contribute to the lower 
number of adult GATA4 regions, this does not account for the "Adult-Specific" GATA4 
regions bound in adult and not fetal heart.
Adult and fetal GATA4 regions differed considerably in their location. 83.7% of fetal 
GATA4 regions were distal to TSSs (defined as beyond −2 to +2 kb of the TSS), consistent 
with our prior findings in the HL1 cardiomyocyte-like cell line8. However, adult GATA4 
regions shifted markedly towards proximal binding, as only 46.6% were distally located. 
Similarly, 93.3%, 44.9%, and 50% of Fetal-Specific, Shared, and Adult-Specific GATA4 
regions were distally located, respectively (Fig. 4c and Supplementary Fig. 3c).
Fetal-Specific, Shared, and Adult-Specific GATA4 regions were associated with different 
functional terms (Fig. 4d and Supplementary Fig. 3d–e). Distal GATA4 sites that were 
Fetal-Specific or Shared were associated with GO terms pertaining to heart development 
(orange bars, Fig. 4d). Distal Fetal-Specific GATA4 regions were also linked to “positive 
regulation of cell cycle process” and “regulation of TGFβ receptor signaling pathway”, 
consistent with GATA4 regulation of cardiomyocyte proliferation4,19 and its interaction 
with Smad proteins, nuclear targets of TGFβ signaling20.
Cardiac TFs collaboratively bind to chromatin loci8, and changes in GATA4 binding 
partners might account for altered chromatin occupancy during development21,22. To 
identify potential partners, we performed de novo motif discovery on GATA4-bound regions 
(Fig. 4e). As expected, the GATA motif was highly over-represented in GATA4-bound 
regions from fetal and adult heart, with adult-specific proximal regions (2171 regions) being 
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the sole exception. The co-enriched motifs of other TFs were mostly distinct between fetal-
specific and adult-specific GATA4-bound regions. For example, the MEF2 motif was 
strongly enriched in Fetal-Specific and Shared GATA4-bound regions, and the TEAD1 
motif was enriched amongst Fetal-Specific peaks. Shared distal peaks were highly enriched 
for E-box motifs, which are often bound by bHLH proteins such as HAND1/223. Adult 
GATA4 regions were highly enriched for the EGR motif, particularly amongst proximal 
GATA4 regions. Scanning these regions for the consensus binding motifs for GATA4, 
MEF2, TEAD1, and EGR1 reinforced these conclusions (Supplementary Fig. 3f). These 
changes in associated motifs might reflect altered expression of transcriptional regulators 
between fetal and adult heart. For instance, the expression of MEF2A and TEAD1 was 
significantly lower in adult compared to fetal heart (Fig. 4f).
We asked if the extent of GATA4 occupancy is related to target gene expression level. 
GATA4-bound genes were more highly expressed than genes lacking GATA4 binding in 
both fetal and adult heart (Fig. 4g). However, the strength of GATA4 binding did not 
correlate with gene expression level in either fetal or adult heart. These data are consistent 
with our analysis of the interplay between GATA4 binding, H3K27ac enrichment, and gene 
expression in the fetal heart, and suggest that this analysis likely also pertains to the adult 
heart.
The chromatin landscape of GATA4-bound regions
To further investigate the relationship of GATA4 chromatin occupancy to features of the 
chromatin landscape, we used ChIP-Seq to establish genome-wide maps of key epigenetic 
marks (H3K27ac, H3K4me1, H3K27me3, and H3K4me3) and RNA polymerase II 
(RNAPII) in fetal and adult heart ventricles (Supplementary Data 1). The pattern of these 
chromatin landscape features at TSSs and at active enhancers (defined by H3K27ac 
enrichment distal to TSSs; Supplementary Fig. 4a) was consistent with previous 
reports15,24–26, supporting the fidelity of these data.
We analyzed the aggregate signal for each of these marks centered around fetal and adult 
GATA4 peaks, each subdivided into locations proximal or distal to TSSs (Fig. 5a and 
replicate Supplementary Fig. 4b). GATA4 peaks were depleted for H3K27me3, a repressive 
mark. Shared distal and proximal GATA4 regions were enriched for H3K27ac (Fig. 5a v-
viii), an activating mark found at enhancers and also present near the TSS15. These regions 
were also enriched for H3K4me3 and RNAPII, activating marks most highly enriched at 
TSSs27 and also found at enhancers28,29. H3K4me1, a mark found at enhancers and to a 
lesser extent at promoters30, also was enriched in the Shared GATA4 regions, with the 
exception of Shared proximal regions of the adult heart. Thus, Shared GATA4-bound 
regions featured chromatin landscapes rich in activating marks, in both fetal and adult heart.
We next considered distal, stage-specific GATA4 binding sites (Fig. 5a, boxes i and x). 
These were also enriched for H3K27ac, suggesting that many of these regions are functional 
enhancers. Distal Adult-Specific GATA4 regions had H3K27ac enrichment in adult but not 
fetal heart (Fig. 5a, box×vs ix), suggesting that many of these regions are adult-specific 
functional enhancers. Consistent with this conclusion, there was also significant H3K4me3 
and RNAPII enrichment at the large majority of these sites in adult but not fetal heart. 
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However, a different pattern was observed at distal Fetal-Specific GATA4 regions – these 
showed H3K27ac enrichment that was relatively weaker than seen at the Adult-Specific 
GATA4 regions, and that was not substantially different between fetal and adult stages (Fig. 
5a, box i vs ii). Furthermore, these fetal distal peaks lacked H3K4me3 and RNAPII (arrows, 
Fig. 5a box i).
To further investigate the chromatin landscape at GATA4-occupied distal enhancers, we 
analyzed tag heat maps of GATA4+ H3K27ac+ distal regions (Fig. 5b and replicate 
Supplementary Fig. 4c). 79.6% of distal Adult-Specific GATA4 regions displayed a typical 
enhancer signature (H3K27ac+, H3K4me3+, RNAPII+) in the adult heart, which we refer to 
as type I distal GATA4 regions, whereas 96.4% of distal Fetal-Specific GATA4 regions 
displayed the less typical enhancer signature (H3K27ac+, H3K4me3−, RNAPII−) in the fetal 
heart, which we designated type II distal GATA4 regions. Shared GATA4 regions also 
exhibited predominantly (80.1%) the type II chromatin signature in fetal heart. Interestingly, 
during development 775 (41.7%) type II regions acquire H3K4me3 and RNAPII to become 
type I regions, whereas only 1 (<0.1%) type I regions lost H3K4me3 and RNAPII to become 
type II (Supplementary Fig. 4d). As a result, Shared GATA4 regions have predominantly 
(74%) a type I chromatin signature in the adult heart. Together, these data indicate that distal 
fetal GATA4 regions have a significantly different chromatin signature than adult GATA4 
regions (Fisher exact P<0.0001).
We examined the biological significance of the type II GATA4 region chromatin signature. 
To determine if these regions have in vivo heart enhancer activity, we reviewed available in 
vivo heart enhancer test data. In our enhancer testing and in the VISTA enhancer database31, 
there were 97 GATA4+ H3K27ac+ regions with a type II fetal heart chromatin signature. 66 
(68%) had heart activity. Only 6 regions with a type I fetal heart chromatin signature were 
tested in the in vivo enhancer assay, and 4 (66%) were positive. Both type I and type II fetal 
GATA4 regions were over-represented for Gene Ontology (GO) terms related to heart 
development (Fig. 5c; orange bars). Type II regions were also related to TGF-beta signaling 
and cell cycle regulation, processes known to be under GATA4 regulation20,32. These 
results indicate that a subset of GATA4+ H3K27ac+ regions with type I or II signatures are 
bona fide heart enhancers.
We next asked whether enrichment of H3K27ac at fetal distal type I or type II peaks differed 
in their dependence on GATA4. We analyzed our data on H3K27ac occupancy in G4CKO 
versus control E12.5 heart ventricle, comparing the change of H3K27ac observed at type I 
and type II distal Fetal-Specific and Shared GATA4 regions (Fig. 5d–f). In control hearts, 
overall H3K27ac signal was significantly lower at type II compared to type I regions (Fig. 
5f), and GATA4 inactivation reduced H3K27ac enrichment so that only 23% of type II 
regions were identified as H3K27ac peaks in mutant hearts (Fig. 5d,e). In comparison, 
49.3% of type I peaks continued to be identified as H3K27ac peaks in mutants (Fisher 
P=1.47E-18). The same was true of Shared distal regions, where only 31% of type II regions 
retained H3K27ac in GATA4 knockout, compared to 89.1% of type I regions (P=8.21E-36). 
These results indicate that the chromatin landscape of regulatory regions influences their 
dependence on GATA4 for establishment or maintenance of H3K27ac.
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Reactivated and new enhancers in adult pressure overload
GATA4 plays an integral role in pathological cardiac hypertrophy, in which stress such as 
pressure overload induces abnormal cardiomyocyte growth and gene expression1,5. 
Reactivation of a “fetal transcriptional program”, in which genes normally downregulated 
between fetal and adult heart are re-expressed in pressure overload, has been described as an 
integral component of cardiac hypertrophy. While individual examples of fetal gene 
reactivation are well described, the extent to which the transcriptional circuitry of the fetal 
heart is redeployed in pathological hypertrophy is unknown.
We used RNA-seq to compare cardiac gene expression in mice with pressure overload 
induced by a surgically placed ligature around the aorta (“Band”) to mice that had 
undergone sham operation (“Sham”). Out of 1016 hypertrophic genes (Supplementary Data 
3), defined as genes upregulated by more than 0.5-fold (log2 scale = 1.41-fold linear scale) 
in Band, 383 (37.7%) were associated with distal Fetal-Specific GATA4 regions (Fig. 6a). 
In comparison, only 86 (8.5%), 125 (12.3%), and 204 (20.1%) regions with distal Adult-
Specific, Shared, and no GATA4 binding were associated with hypertrophic genes, 
respectively. GO term analysis of the overlapped genes yielded cardiac-related terms in the 
distal Fetal-Specific and Shared groups (orange bars, Fig. 6a). In contrast, GO term analysis 
of hypertrophic genes with Adult-Specific or no GATA4 binding did not yield functional 
terms related to the heart.
Next, we examined GATA4 binding changes induced by pressure overload. GATA4 
bioChIP-seq identified 1847 and 3772 distal GATA4-occupied regions in Sham and Band 
heart, respectively. Only 908 GATA4 regions (49%) were shared between Sham and Band 
(Fig. 6b), suggesting that GATA4 occupancy significantly changes in heart disease. Distal 
GATA4 regions identified in Band only (“Band-Induced”) mapped to 1783 genes, which we 
referred to as GATA4+ Band-Induced genes. Most GATA4+ Band-Induced genes 
extensively overlapped (86.2%; P < 1.00E-200) with genes associated with distal Fetal-
Specific GATA4 regions (Fig. 6c), while the extent of overlap with genes associated with 
distal Adult-Specific GATA4 regions was far less (14%; P < 1.8E-6).
The genes related to distal GATA4 regions that were found in both Band-Induced and Fetal-
Specific peak sets showed significant overlap with hypertrophy genes (Fig. 6d; 22.1%; p = 
1.38E-23). These overlapped genes were enriched for heart-related GO terms (orange bar, 
Fig. 6d). In contrast, the genes associated with Sham-Specific and Fetal-Specific distal 
GATA4 regions overlapped less extensively with hypertrophy genes (4.5%; p = 8.32E-05) 
and these overlapped genes were not enriched for heart-related GO terms.
To further investigate how disease- and development-associated changes in GATA4 
occupancy relate to one another, we compared GATA4 bioChIP-seq signals from fetal, 
sham and band samples. Figure 6e shows an illustrative example in which two regions, 
highly enriched for GATA4 in the fetal heart, are adjacent to Ankrd1, a gene upregulated in 
Band. In Sham-operated adult heart, the bioChIP-seq signal was sub-threshold, but returned 
with banding (Fig. 6e).
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Displaying all distal regions with GATA4 enrichment in band but not sham (Band-Induced 
regions), categorized by their overlap with Fetal-Specific, Adult-Specific, and Shared 
regions, yielded an overview of the relationship of GATA4 chromatin occupancy in 
development and disease (Fig. 7a; Supplementary Data 4; Supplementary Fig. 5a–b). This 
analysis defined a class of Band-Induced regions with little GATA4 occupancy in normal 
fetal or adult heart (“New”, Fig. 7a), and three additional classes that overlapped with Fetal-
Specific, Adult-Specific, and Shared regions. This “New” category contained the most 
regions, indicating that cardiac stress induced GATA4 to occupy regions that it does not 
bind in normal heart development. Among the genes associated with these regions were 
hypertrophy regulators Tead1, Fhl1, Ankrd1, and SWI/SNF core component Smarca2 
(Supplementary Fig. 5a). Additional Band-Induced GATA4 peaks represented restored 
GATA4 binding to Fetal-Specific peaks at genes such as Zfpm2 (Fog2) and Hdac9 
(Supplementary Fig. 5b).
Most transcriptional regulatory sequences exhibit hypersensitivity to digestion by DNase 
I.33 To further assess whether these distal GATA4-bound regions likely represent regulatory 
sequences, we evaluated their DNase I hypersensitivity using publicly data for the normal 
adult mouse heart33 (Fig. 7b). The large majority (75.4%) of the Band-Induced GATA4 
Regions overlapped with DNase I hypersensitive sites (DHSs). Thus, most distal Band-
Induced GATA4-regions had an open chromatin conformation consistent with active 
transcriptional regulatory regions, and most of these regions already possessed this open 
signature in the normal adult heart. Interestingly, amongst the Band-Induced GATA4 
regions that were "New" or reactivated Fetal-Specific, regions without DHS signal in the 
normal adult heart were significantly more frequent than in the other two groups (Fig. 7b; 
42.9% (P =1.2E-38) and 10.3% (P=1.90E-12) in New and Fetal-specific categories, 
respectively). These may represent disease transcriptional enhancers recruited as part of the 
cardiac hypertrophy transcriptional program.
We also analyzed GATA4 occupancy of proximal Band-Induced regions to determine the 
relationship to GATA4 occupancy in normal fetal and adult heart (Supplementary Fig. 5c–
d). This genome-wide analysis only yielded 42 (7.6%) and 58 (10.5%) "Fetal-Specific" and 
"New" regions, respectively. These sets of regions did not yield any significant GO terms 
nor were they enriched in known TF motifs. These results indicate that pressure overload 
does not lead to substantial shift of GATA4 binding to Fetal-Specific or New proximal 
regions and that changes in distal rather than proximal GATA4 binding likely play a 
dominant role in regulation of the hypertrophic response.
To identify partner TFs that might drive GATA4 occupancy of distal regions in pressure 
overload, we performed de novo motif discovery using the four classes of distal, Band-
Induced GATA4 regions (Fig. 7c). The distal Band-induced peaks that overlapped with 
GATA4 regions in fetal and/or adult heart were enriched for the consensus GATA motif, 
while the “New” group of distal Band-induced peaks contained an atypical GATA motif. 
Interestingly, Band-Induced GATA regions overlapping fetal GATA4 regions, and “New” 
GATA4 regions, were also enriched for the motif of NFAT (Fig. 7c), a calcium-responsive 
TF family essential for heart development34 and the heart's response to pathological stimuli 
such as pressure overload35. Scanning the Band-Induced peaks for the consensus GATA and 
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NFAT motifs showed that most regions with banding-induced restoration of fetal GATA4 
occupancy contained both GATA and NFAT motifs (Fig. 7d). Indeed, 85% of the regions 
with the GATA motif also contained an NFAT motif (Fig. 7e), and the motifs were usually 
located less than 60 bp from each other (Fig. 7f). Among the genes relevant to pressure-
overload hypertrophy that contained GATA4 bound regions with NFAT motifs were Ryr2, 
Myocd, Vegfa, Camk2d, and the mineraldocorticoid nuclear receptor Nr3c2 (Supplementary 
Data 4). These data corroborate prior anecdotal data indicative of an important role for 
NFAT-GATA4 interaction in the cardiac hypertrophic response, and moreover identify 
candidate enhancers regulated by this interaction.
We analyzed the functional annotations of genes associated with the Band-Induced GATA4 
regions (Supplementary Fig. 5e). Distal Band-Induced GATA4 regions overlapping Shared 
GATA4 regions were enriched for functional terms related to muscle development and heart 
contraction, as well as mitochondrial organization. Distal Band-Induced GATA4 regions 
overlapping Fetal-Specific peaks were associated with muscle and artery development, and 
the subset of these regions that contained both NFAT and GATA motifs was likewise 
associated with functional terms related to muscle differentiation and cytoskeleton 
organization (P < 2E-05).
To further assess the transcriptional regulatory activity of distal Band-Induced GATA4 
regions, we selected 10 regions linked to genes upregulated in pressure overload. The 
regions were cloned into luciferase reporter vectors containing basal promoters. Their 
responsiveness to GATA4 was tested by co-transfection with GATA4 or GATA4 plus p300. 
GATA4 alone significantly increased transcriptional enhancer activity in 9 of the 10 regions, 
and introduction of p300 further boosted their activity (Fig. 7g). Next, we tested the 
responsiveness of these regulatory elements to activation of the hypertrophic program in 
cardiomyocytes. The enhancer-reporter constructs were transfected into neonatal rat 
ventricular myocytes treated with the hypertrophic agonist phenylephrine (PE) or vehicle 
control. PE significantly increased the activity of 4 out of 10 enhancers (1.3–22.9 fold 
stimulation; Fig. 7h), whereas six enhancers were not detectably stimulated by PE. Testing 
these adult enhancers in neonatal cardiomyocytes possibly reduced the sensitivity of this 
assay.
Together, these data show that pressure overload activates a hypertrophic program involving 
GATA4 recruitment to new disease enhancers that were not occupied by GATA4 during 
development, as well as restoration of GATA4 binding to a subset of fetal GATA4 
enhancers.
DISCUSSION
The dynamic changes in transcription factor chromatin occupancy that occur during 
development and disease, its relationship to the chromatin environment, and its effect on 
transcriptional regulation, are important incompletely resolved questions. Here, we 
investigated in depth the chromatin occupancy of the key cardiac transcription factor 
GATA4 and show that its chromatin occupancy changes dynamically in heart development 
and disease.
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We used two independent GATA4 pull-down strategies, streptavidin pull-down of in vivo 
biotinylated GATA4 and immunoprecipitation, to identify GATA4-bound regions. 
Establishing a knockin, epitope tagged mouse line is time consuming and resource intensive. 
The investment in generating the in vivo biotinylated allele proved fruitful, as bioChIP-seq 
was highly efficient and reproducible and yielded more peaks with higher signal than 
obtained through antibody-mediated ChIP-seq. Antibody-mediated ChIP-seq remained 
valuable as an orthogonal method that helped us further hone in on high confidence 
GATA4-bound regions, but was more variable and far less sensitive.
GATA4 chromatin occupancy changed dramatically through development, in concert with 
its changing function. GATA4 regions in the fetal heart were predominantly distal from 
TSSs. In adult heart, we observed a dramatic shift of GATA4 regions to TSS proximal 
locations. Motif analysis indicated that the selection of GATA4 binding sites is influenced 
by its interactions with TFs: MEF2, TEAD1, and E-box motifs were over-represented in 
fetal GATA4 regions, while motifs of EGR1, a TF implicated in regulation of cardiac 
hypertrophy36, were over-represented in adult GATA4 regions.
An important mechanism for GATA4 transcriptional activity was promoting deposition of 
activating histone marks near its binding sites. Through multiple lines of data, we showed 
that GATA4 recruits the histone acetyltransferase p300, which deposits H3K27ac deposition 
at cardiac enhancers to stimulate transcription. These findings provide insights into how 
transcription factors such as GATA4 shape the chromatin environment to regulate gene 
expression.
The chromatin landscape of distal GATA4+ H3K27ac+ prospective enhancers was different 
between fetal and adult heart. In adult heart, most of these regions were enriched for 
RNAPII and H3K4me3, which are commonly found at enhancers24,29. In contrast, these 
regions largely lacked RNAPII and H3K4me3 enrichment in fetal heart. Regions lacking 
RNAPII and H3K4me3 had a greater reliance on GATA4 for their H3K27ac enrichment. 
One interpretation of these observations is that initially established enhancers lack RNAPII 
and H3K4me3 enrichment, and in this nascent state require GATA4 to maintain H3K27ac. 
With time, the enhancers become more well established , accumulate RNAPII and 
H3K4me3, and reduce their dependence upton GATA4 for maintenance of H3K27ac. 
Additional studies will be required to test these hypotheses and to determine whether these 
observations are restricted to GATA4 enhancers or are generalizeable to other enhancer 
classes.
Pathological stress, such as pressure overload, alters cardiac gene expression and promotes 
the re-expression of genes predominantly expressed in the fetal heart. This observation has 
been attributed to reactivation of a fetal gene program, which implies restoration of TF 
binding to fetal enhancers. We rigorously tested this model by comparing GATA4 
chromatin occupancy in development versus pressure overload. At the gene level, there was 
a clear relationship between hypertrophic genes and distal fetal GATA4 occupancy patterns. 
Furthermore, a subset of distal Band-Induced GATA4 regions did indeed reflect restoration 
of fetal GATA4 binding. However, reactivation of fetal regulatory regions constitutes a 
small portion of the transcriptional response of the diseased adult heart. Whereas 20.5% of 
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Band-Induced GATA4 regions represented re-occupancy of fetal regions, 40.5% were due to 
GATA4 binding to transcriptional regulatory elements not normally bound by GATA4 in 
the normal developing or adult heart. These “New” GATA4-bound regions suggest a stress-
induced, disease specific transcriptional program.
Two mechanisms likely contribute to GATA4 recruitment to new distal elements in cardiac 
hypertrophy. First, the majority of distal elements that overlapped restored fetal binding 
contained both GATA4 and NFAT motifs. This interaction was previously reported for 
Nppb and its general significance was inferred from this anecdotal example.35 Our 
observation provides unbiased, genome-wide evidence for the importance of GATA4-NFAT 
co-binding in driving the hypertrophic response and the reactivation of fetal gene 
expression, and identifies many other enhancers and genes that are likely regulated through 
this mechanism.
Second, we found that 43% of Banding-Induced GATA4 occupancy of "New" distal sites 
occurred at sites that have a "closed" chromatin configuration in the normal heart, as 
assessed by lack of DNaseI hypersensitivity. GATA4 has been shown to displace histones 
from chromatinized DNA. This "pioneer" activity has been proposed to permit GATA4 to 
initiate formation of transcriptional regulatory complexes on closed chromatin.37 We 
propose that GATA4 occupies "New" loci in pressure overload through its pioneer activity. 
The characteristics that define these "New" loci and their functional significance will be 
fruitful areas for future study.
Methods
Mice
Gata4flbio (Jackson Labs, stock #018121)11, Rosa26BirA (Jackson Labs, stock #010920)38, 
cTNTcre39, and Gata4flox (Jackson Labs, stock #008194)6 alleles were described previously. 
Experiments were performed according to protocols approved by the Institutional Animal 
Care and Use Committee.
Fetal mice were collected at E12.5. Hearts were collected from adult mice at 6–10 weeks of 
age. The apical half of the heart of fetal and adult hearts was used for chromatin or RNA 
analysis. Sham and Band (ascending aortic band) were performed as described40. Hearts 
were collected 2 weeks after the operation.
ChIP and RNA preparation
Ventricular apex tissue was used for chromatin and RNA preparation. Both bioChIP and 
antibody-based ChIP were performed as described9. For bioChIP, minced freshly collected 
tissues were crosslinked with 1% formaldehyde for 15 minutes at room temperature then 
terminated with glycine. After PBS rinse, nuclei were isolated by resuspending in Hypotonic 
Lysis Buffer (20 mM HEPES pH 7.5, 10 mM KCl, 1 mM EDTA, 0.1 mM Na3VO4, 0.1 mM 
0.2% (vol/vol) Nonidet P40 (NP-40), 10% (vol/vol) glycerol plus protease inhibitor cocktail) 
and dounce homogenized. Pelleted nuclei were then resuspended in 20 mM Tris (pH 8.0), 2 
mM EDTA, 150 mM NaCl, 0.1% SDS, 1% Triton X-100 (TX100), and protease inhibitors. 
Samples were sonicated, yielding an average fragment size of ~200 bp. After preclearing 
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with Protein G beads, samples were incubated with streptavidin beads (Dynabeads 
Streptavidin M280) at 4°C overnight. Beads were washed with a series of buffers containing 
2% SDS, 0.1% deoxycholate, 1% TX100, and high and low salt concentrations. After DNA 
elution, cross-link reversal, and Proteinase K digestion, and purification with Qiaquick 
columns (Qiagen), Illumina sequencing libraries were constructed. Antibody-based ChIP 
was performed as above but without the 2% SDS wash step.
ChIP-qPCR values were expressed as fold-enrichment. Antibodies used were: GATA4, 
Santa Cruz sc-1237x; H3K4me3, Active Motif 39159; H3K4me1, Abcam ab8895; 
H3K27ac, Abcam ab4729; H3K27me3, Millipore 17-622; RNAPII, Millipore 17-672.
RNA-seq libraries were prepared as described41. Briefly, mRNA was isolated from total 
RNA using Dynabeads Oligo(dT), followed by first and second strands synthesis. RNA-seq 
libraries were prepared from fragmented double stranded cDNA using ScriptSeq v2 
(Epicenter).
Transgenic mouse reporter assay
Genomic regions covering selected GATA4 regions were amplified and inserted upstream of 
a minimal hsp68 promoter-LacZ reporter gene as described previously13. Transgenic mouse 
embryos were generated by pronuclear injection. Embryos were collected at E11.5 and 
stained for LacZ activity as previously described13. A region was scored as yielding positive 
heart activity if three or more transient transgenics from the same construct yielded a 
reproducible cardiac staining pattern.
Luciferase reporter assay
Genomic regions were amplified and cloned upstream of a minimal promoter in XhoI and 
HindIII digested pGL4.23 using the Gibson assembly method. Neonatal rat ventricular 
myocytes (NRVM) at postnatal day 1 were isolated and co-transfected with pGL4.23-
enhancers and phRL-TK with X-tremeGENE HP transfection reagent (Roche), stimulated 
with or without 100 μM phenlephrine (PE) for 30 hrs before the the dual-luciferase assay. 
Luciferase activity was normalized to Renilla luciferase activity and expressed as fold 
change against the empty vector pGL4.23.
Chip-seq data analysis
Illumina libraries were sequenced on a Hiseq 2000. Single end 50 nt reads were aligned to 
mouse reference genome (mm9) using BWA (version 0.5.9)42. Reads with no more than 2 
bp mismatches and uniquely mapped to reference genome were retained. For duplicated 
reads with exactly the same genomic coordinates, only one read was kept. Read density was 
expressed as the number of reads per 10 million uniquely mapped, non-duplicated reads.
The peak caller program MACS (version 1.4)43 was used to identify peaks with the 
following parameter settings: --bw=200 --keep-dup=1. We used IGV (version 2.3)44 or the 
UCSC Genome Browser to visualize bigwig data tracks. For each track, read number was 
normalized per 10 million aligned reads. Peaks were assigned to the gene with the closest 
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TSS. Proximal was defined within ±2 kb of the TSS, while remaining regions were defined 
as distal.
Aggregation plots were generated using Homer (version 3.1)45. 40 kb centered on each peak 
with 100 bp bin size was used for P300 ChIP-seq datasets, while 4 kb peak region and 10 bp 
bin size was used for all the other datasets. For heatmaps, tag density matrices were 
calculated using Homer. 4kb centered on each peak with 50 bp bin size was used for Figure 
5B, while 2kb centered on each peak with 25 bp bin size was used for Figure 7A. Values 
plottered were log2 transformed fold-enrichment (ChIP signal divided by input signal).
Genome regions were associated to the gene with the nearest TSS.
RNA-seq analysis
Paired-end, 50 nt RNA-Seq reads were mapped to mouse reference genome (mm9) using 
TopHat (version 1.4.0)46 with default parameter settings. The mapped reads of each gene 
were counted by htseq-count (version 0.5.4)47 with the following parameter setting: -i 
gene_name -a 20 -s no. Expression levels for each gene were calculated by Fragments Per 
Kilobase of Transcript (longest transcript of gene) per Million mapped fragments (FPKM). 
Gene expression value was log2 transformed (FPKM+1) for further analysis. An expressed 
gene was defined as a gene with FPKM>0 in at least one condition. Differentially expressed 
genes were identified by a log2 fold-change of at least 0.5
Motif analysis
De novo motif detection was analyzed using DREME48 with the following parameters: -e 
0.00001 -mink 5 -maxk 15. We mapped de novo motifs to a known motif database using 
TOM TOM49 with default settings. The Motif database was constructed from MEME 
suite50. Only vertebrate motifs were retained. De novo motifs that did not match known 
motifs were not used. Motifs with p-value<10−8 identified by DREME and p-value<10−3 
identified by TOM TOM were collected for generating the motif heatmap. Motif occurrence 
within peaks was calculated with FIMO51 with default parameters for fetal, adult and shared 
Gata4 peaks, and q-value<0.5 for band Gata4 peaks.
GO analysis
The functional enrichment of peak regions for Gene Ontology (GO) terms was performed 
using GREAT52 with default parameters. The top 20 terms in the “biological process” 
section were used. Lists of genes were analyzed for GO term enrichment using DAVID53. 
Terms within the top 20 "GOTERM_BP_FAT" category were used.
Quantitative PCR and Western Blotting
Real time PCR was used to measure relative ChIP enrichment or gene expression. 
Quantitative PCR was performed using Sybr green chemistry (VeriQuest master mix; 
Affymetrix). Primer sequences are listed in Supplementary Data 5. Western blotting was 
performed using standard protocols. Full uncropped blots are provided in Supplementary 
Figures 6 and 7.
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Statistical analysis
For bar charts, data is presented as mean ± SEM. For whisker plots, the center line indicates 
the median, the box represents the interquartile range, and the whiskers represent the 
minimum and maximum values. Hypergeometric test was used to assess the significance of 
overlaps in Venn diagrams. Mann-Whitney test was used to compare box plots. Statistical 
significance was indicated with: * for p<0.05, ** for p<0.01, ***for p<0.001, **** for 
p<0.0001.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. GATA4 regulates genes expression through GATA4 bound enhancers during 
embryonic heart development
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Figure 2. Selected GATA4 distal regions tested for enhancer activity in E11.5 transgenic 
embryos
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Figure 3. GATA4 promotes deposition of H3K27ac at distal regulatory regions
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Figure 4. Dynamic GATA4 occupancy from fetal to adult heart controls distinct gene programs
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Figure 5. The chromatin landscape of GATA4 regions influences their reliance on GATA4 for 
H3K27ac accumulation
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Figure 6. GATA4 chromatin occupancy and gene expression changes in pressure overload
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Figure 7. The cardiac hypertrophic transcriptional program reflects re-establishment of fetal 
GATA4 binding and acquisition of new GATA4 binding sites
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Table 1
List of selected enhancers tested in the transient transgenic enhancer assay.
Gene ID Dist to TSS (bp) Activity G4 dependent
Ednra 1 834 Negative
Ednra 2 16489 Negative
Ednra 3 52246 Heart& Face
Ednra 172 −264084 Heart No*
Hey2 4 −386564 Heart
Hey2 5 −210660 Heart
Hey2 6 −192203 Somites
Hey2 7 −430592 Heart
Hey2 8 −155535 Heart-oft
Hey2 9 −185613 Negative
Kcne1 10 14167 Heart
Kcne1 11 18063 Midbrain
Hopx 12 −35428 Heart
Wisp1 104 −76686 Heart Yes
Ssh2 146 160814 Heart Yes
Smarcd3 13 −3000 Heart Yes**
ID numbers over 100 were obtained from the VISTA enhancer browser31 and number 13 was reported previously8. "Heart-oft" indicates selective 
activity in the outflow tract of the heart. “G4 dependent” indicates effect of GATA site mutation on in vivo enhancer activity (Fig. 2b).
*
a residual GATA site with marginal GATA4 occupancy was left unmutated.
**GATA site requirement was unmasked by TBX5 binding site mutation.8
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